Expression of Caudal-Type Homologous Transcription Factor-2 (CDX2) in Duodenal Carcinoma and its Relationship with Prognosis.
CDX2 serves as an autonomous prognostic determinant in individuals diagnosed with duodenal cancer. Notably, patients exhibiting positive CDX2 expression demonstrate a considerably improved prognosis compared to those with negative CDX2 expression. CDX2 may play an important role as an tumor suppressor gene in the development of duodenal cancer. CDX2 can be used as an important factor for evaluating the prognosis of patients with duodenal cancer, and it has the potential to be a target for duodenal cancer therapy.
Authors
- Yitian Chen (ORCID: https://orcid.org/0000-0001-5259-251X)
- Xiao‐Dong Jiao (ORCID: https://orcid.org/0000-0002-9663-8548)
- Zhihui Yang
- Jie Li (ORCID: https://orcid.org/0000-0002-7163-8242)
- Xiaoyuan Chu (ORCID: https://orcid.org/0000-0002-7917-7874)
- Jun Pan (ORCID: https://orcid.org/0000-0002-4031-5766)
Publication Details
- Journal
- PubMed
- Published
- 2024-12-01
- Citations
- 1
- Primary Topic
- Digestive system and related health
- Type
- article
- Field-Weighted Citation Impact
- 0.55